Question to SPCEo on Liver Therapy ladySPCEO, is the Liver Therapy consultant still covering the sector and writing up on the companies or did she get blown out in the down draft of these names? Just wondering what she thinks of some of the new names like 89Bio and Akero, also if she even commented on the transcriptome data from THTX. Haven't seen her mentioned in a while so wondering.